MariMed

MariMed, established in 2011, is a prominent multi-state cannabis operator specializing in the design, development, financing, and optimization of medical cannabis cultivation, production, and dispensary facilities. The company provides comprehensive management services to these operations, ensuring efficiency and compliance across its network. With a strategic focus on the burgeoning cannabis industry, MariMed leverages its expertise to manage complex regulatory environments and operational demands. The company's commitment to quality and innovation underpins its service offerings, positioning it as a key player in the sector.

Operating across multiple states, MariMed manages a network of facilities and employs a dedicated workforce. The company's operational scale is reflected in its employee range of 500-1,000 employees and its presence across 6 distinct locations. This infrastructure supports its core business of developing and managing cannabis-related enterprises. For insights into the individuals driving these operations, one can explore Meet MariMed's team. MariMed's business model emphasizes a hands-on approach to facility management, from seed to sale, ensuring a consistent product and service delivery.

Financially, MariMed reported a significant revenue of $159.8M. The company has secured substantial funding, including debt financing and share placements, to fuel its expansion and operational capabilities. Notable funding rounds include a $35 million debt facility in January 2023 and a $46 million share placement in March 2021. MariMed competes within a dynamic market against entities such as Verano and PharmaCann, among others. Investors and stakeholders can Explore financial highlights for a deeper dive into its fiscal performance and investment history.